ES2110998T3 - Procedimiento para la determinacion de las trombopenias. - Google Patents
Procedimiento para la determinacion de las trombopenias.Info
- Publication number
- ES2110998T3 ES2110998T3 ES91915653T ES91915653T ES2110998T3 ES 2110998 T3 ES2110998 T3 ES 2110998T3 ES 91915653 T ES91915653 T ES 91915653T ES 91915653 T ES91915653 T ES 91915653T ES 2110998 T3 ES2110998 T3 ES 2110998T3
- Authority
- ES
- Spain
- Prior art keywords
- determination
- inducer drug
- thrombocytopeniae
- inducer
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010043554 thrombocytopenia Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 239000000411 inducer Substances 0.000 abstract 4
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 210000001772 blood platelet Anatomy 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rehabilitation Therapy (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Physiology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Record Carriers (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
- Electrophonic Musical Instruments (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A LA DETERMINACION DE TROMBOCITOPENIAS INDUCIDAS POR UNA DROGA INDUCTORA. SEGUN LA INVENCION, SE UTILIZA PARA DICHA DETERMINACION UNA SUSTANCIA ANTIGENICA ELEGIDA ENTRE EL CONJUNTO CONSTITUIDO POR LAS FRACCIONES QUE (I) ESTAN PRESENTES EN LAS PLAQUETAS SANGUINEAS Y LIBERADAS DE DICHAS PLAQUETAS SANGUINEAS POR LISIS, Y (II) TIENEN UNA GRAN AFINIDAD RESPECTO DE LA DROGA INDUCTORA (Z) Y/O DE LOS COMPLEJOS DE DICHA DROGA INDUCTORA CON LAS PLAQUETAS, ESTANDO DESTINADA DICHA SUSTANCIA ANTIGENICA A REACCIONAR CON UN MATERIAL ANTICUERPO ANTI (Y) CONTENIDO EN EL PLASMA A PROBAR Y DIRIGIDO CONTRA LA DROGA INDUCTORA, SUS FRAGMENTOS O LOS PRODUCTOS QUE CONTIENEN DICHA DROGA INDUCTORA O UNO DE SUS FRAGMENTOS. LA INVENCION SE REFIERE TAMBIEN A UN PROCESO PARA LA DETERMINACION DE DICHAS TROMPOCITOPENIAS, EN PARTICULAR LAS INDUCIDAS POR HEPANIMA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9010190A FR2665769B1 (fr) | 1990-08-09 | 1990-08-09 | Determination des thrombopenies notamment induites par l'heparine au moyen du facteur plaquettaire 4. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2110998T3 true ES2110998T3 (es) | 1998-03-01 |
Family
ID=9399577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES91915653T Expired - Lifetime ES2110998T3 (es) | 1990-08-09 | 1991-08-09 | Procedimiento para la determinacion de las trombopenias. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0495971B1 (es) |
| JP (1) | JP2821951B2 (es) |
| AT (1) | ATE160448T1 (es) |
| DE (1) | DE69128238T2 (es) |
| ES (1) | ES2110998T3 (es) |
| FR (1) | FR2665769B1 (es) |
| WO (1) | WO1992002823A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585243A (en) * | 1993-09-15 | 1996-12-17 | The Blood Center Of Southeastern Wisconsin, Inc. | Method of detecting cytopenia that is mediated by drug-dependent antibody binding to blood cells |
| US5972717A (en) * | 1995-05-10 | 1999-10-26 | The Blood Center Research Foundation, Inc. | Method and kit for detecting heparin induced thrombocytopenia |
| FR2738916B1 (fr) * | 1995-09-20 | 1997-11-14 | Stago Diagnostica | Procede d'identification precoce d'une maladie auto-immune, utilisation dans le domaine du diagnostic et necessaire de dosage pour mettre en oeuvre ce procede |
| WO1998022821A1 (en) * | 1996-11-21 | 1998-05-28 | Merck & Co., Inc. | DETECTION OF ANTAGONIST-DEPENDENT GPIIb/IIIa RECEPTOR ANTIBODIES |
| JP4931821B2 (ja) | 2004-10-04 | 2012-05-16 | アケルス バイオサイエンス インコーポレーテッド | ヘパリン/血小板第4因子抗体の検出法及びキット |
| WO2010024271A1 (ja) * | 2008-08-27 | 2010-03-04 | 三菱化学メディエンス株式会社 | 修飾抗ヘパリン/pf4複合体抗体及びhit抗体標準品 |
| ES2862434T3 (es) * | 2017-08-02 | 2021-10-07 | Siemens Healthcare Diagnostics Products Gmbh | Prueba de unión para el diagnóstico de trombocitopenia inducida por heparina |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4717654A (en) * | 1984-06-19 | 1988-01-05 | Akzo N.V. | Process for solid phase platelet antibody assay |
-
1990
- 1990-08-09 FR FR9010190A patent/FR2665769B1/fr not_active Expired - Fee Related
-
1991
- 1991-08-09 WO PCT/FR1991/000659 patent/WO1992002823A1/fr not_active Ceased
- 1991-08-09 EP EP91915653A patent/EP0495971B1/fr not_active Expired - Lifetime
- 1991-08-09 JP JP3513943A patent/JP2821951B2/ja not_active Expired - Lifetime
- 1991-08-09 AT AT91915653T patent/ATE160448T1/de not_active IP Right Cessation
- 1991-08-09 ES ES91915653T patent/ES2110998T3/es not_active Expired - Lifetime
- 1991-08-09 DE DE69128238T patent/DE69128238T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05502103A (ja) | 1993-04-15 |
| ATE160448T1 (de) | 1997-12-15 |
| WO1992002823A1 (fr) | 1992-02-20 |
| DE69128238T2 (de) | 1998-06-25 |
| EP0495971A1 (fr) | 1992-07-29 |
| FR2665769A1 (fr) | 1992-02-14 |
| EP0495971B1 (fr) | 1997-11-19 |
| DE69128238D1 (de) | 1998-01-02 |
| JP2821951B2 (ja) | 1998-11-05 |
| FR2665769B1 (fr) | 1994-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69329108D1 (de) | Verfahren zur inaktivierung von viren | |
| FI871288A0 (fi) | Menetelmä aprotiniinin valmistamiseksi yhdistelmä-DNA-tekniikalla ja menetelmään soveltuva DNA, ilmentämisplasmidi ja isäntäsolu | |
| ATE177754T1 (de) | Fragmente von prion proteinen. | |
| NO964982D0 (no) | Detektering av reticulocytter | |
| PT90574A (pt) | Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma | |
| FI915150A7 (fi) | Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi | |
| ATA188090A (de) | Verfahren zur verarbeitung von tabakblättermaterial, damit erhaltenes tabakmaterial und dieses enthaltende rauchartikel | |
| NL300009I1 (nl) | Fusie-eiwitten met immuunglobulinedelen, hun bereiding en hun gebruik. | |
| ES553015A0 (es) | Dispositivo para la separacion selectiva de fracciones de especies patologicas y-o toxicas macromoleculares de sangre o de componentes de la sangre | |
| ES2098406T3 (es) | Ensayo funcional y reactivo para la determinacion de fibrinogeno. | |
| FI893428A7 (fi) | TNF-a:n in vitro ja in vivo toksisten ominaisuuksien eliminointi monoklonaalisilla vasta-aineilla ja niistä johdetuilla fragmenteilla | |
| DE59109048D1 (de) | Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben | |
| ES2079621T3 (es) | Procedimiento de identificacion o de titulacion de proteinas y aplicaciones. | |
| Binette et al. | The proteins of synovial fluid: A study of the α1/α2 globulin ratio | |
| ATE160448T1 (de) | Nachweis von thrombopenies | |
| DK0416984T3 (da) | Middel til diagnose af demyeliniserende neuropatier, især dissemineret sklerose | |
| DE3889279D1 (de) | Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B. | |
| ATE191568T1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
| CY1106349T1 (el) | Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c | |
| Laufer | Immunochemical studies of muscle proteins in mature and regenerating limbs of the adult newt, Triturus viridescens | |
| DK0683791T3 (da) | Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf | |
| FI854627A7 (fi) | Menetelmä ja reagenssi plasmassa, seerumissa tai kokoveressä olevan vapaan tyroksiinin kvantitatiiviseksi määrittämiseksi. | |
| FI910324A7 (fi) | Menetelmät ja testipakkaukset ihmisen leukosyyttiantigeeni-DNA:n havaitsemiseksi | |
| DE2961056D1 (en) | Stabilized platelet factor 4 immunoassay standards and radio-immunoassay method | |
| ATE147861T1 (de) | Funktioneller test zur bestimmung der protein s- aktivität |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 495971 Country of ref document: ES |